Fluid vitreous substitutes in vitreo retinal surgery

Indian Journal of Ophthalmology

Volumn 44, Issue 4, 1996, Pages 191-206

  Saxena, Sandeep ^a   Gopal, Lingam ^b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b VISION RESEARCH FOUNDATION   (India)

Author keywords

fluorosilicone; liquid perfluorocarbons; silicone oil; sodium hyaluronate; vitreoretinal surgery

Indexed keywords

FLUOROCARBON; HYALURONIC ACID; SILICONE OIL;

AQUEOUS HUMOR; DIABETIC RETINOPATHY; EYE SURGERY; HUMAN; INSTRUMENTATION; REVIEW; VITREORETINOPATHY;

ANIMALS; FLUOROCARBONS; HUMANS; HYALURONIC ACID; RETINAL DETACHMENT; SILICONE OILS; VITRECTOMY; VITREOUS BODY;

EID: 0030464447     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. Glaser BM. Surgery for prolifertive vitreoretinopathy. In: Ryan SJ, ed. Retina. Vol. III. St Louis, CV Mosby. 1989, p 385.
2. Sparrow JR, Chang S. Vitreous substitutes. In: Albert DM, Jakobiec FA, eds. Clinical Practice, Principles and Practice of Ophthalmology. Philadelphia, WB Saunders Co. 1994, p 1142.
3. Bothner H, Wik O. Rheology of intraocular solutions. In: Rosen ES, ed. Vision and Visual Health Care, Vol. 2 . Viscoelastic materials. New York, Pergamon Press. 1986.
4. Michels RG, Stark WJ, Stirpe M, eds. Sodium hyaluronate in anterior and posterior segment surgery. Padova, Italy, Liviana Press. 1986.
5. Schepens CL. Retinal detachment and allied diseases. Philadelphia, W.B. Saunders, 1983.
6. Fitzgerald CR. The use of Healon in a case of rolled-over retina. Retina. 1: 227, 1981.
7. Brown GC, Benson WE. Use of sodium hyaluronate for the repair of giant retinal tears. Arch Ophthalmol. 107: 1246, 1989.
8. Folk JC, Weingeist TA, Packer AJ. Sodium hyaluronate (Healon) in closed vitrectomy. Ophthalmic Surg. 17: 299, 1986.
9. Chang S. Low viscocity liquid fluorochemicals in vitreous surgery. Am J Ophthalmol. 103: 38, 1987.
10. Stefansson E, McCuen BW II, McPherson SD Jr. Biconcave contact lens for examination and laser treatment of the fundus in normal and gas-filled eyes. Am J Ophthalmol. 98: 806, 1984.
11. Chang S, Zimmerman NJ, Iwamoto T, et al. Experimental vitreous replacement with perfluoro- tributyline. Am J Ophthalmol. 103: 29, 1987.
12. Chang S, Repucci V, Zimmerman NJ, et al. Perfluorocarbon liquids in the management of traumatic retinal detachments. Ophthalmology. 96: 785, 1989.
13. Chang S, Lincoff H, Zimmerman NJ, et al. Giant retinal tears. Surgical techniques and results using perfluorocarbon liquids. Arch Ophthalmol 107: 761, 1989.
14. Chang S, Ozmert E, Zimmerman NJ, et al. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol. 106: 668, 1988.
15. Hammer ME, Rinder DF, Hicks EL, et al. Tolerance of perfluorocarbons, fluorosilicone silicone liquids in the vitreous. In: Freeman HM, Tolentino FI (eds): Proliferative vitreoretinopathy. New York, Springer-Verlag. 1988, p 156.
16. Nabib M, Peyman GA, Clark LC. Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: A preliminary report. Ophthalmic Surg. 20: 286, 1989.
17. Liu KR, Peyman GA, Chen MS. Use of high density vitreous substitutes in the removal of posteriorly dislocated lenses or intraocular lenses. Ophthalmic Surg. 22: 503, 1991.
18. Mathews GP, Ross R, Iwamoto T.Electrophysiological and histological evaluation of retinal tolerance to short-term intravitreal perfluoroethylcyclohexane liquid. Invest Ophthalmol Vis Sci. 31(suppl): 24, 1990.
19. Marin J, Mazanas L, Refojo MF, et al. Foralkyl AC- 6, a perfluorocarbon liquid intravitreous tamponade agent with diminished dispersion tendency. Invest Ophthalmol Vis Sci. 31(suppl): 439, 1990.
20. Flores-Aguilar M, Munguia D, Loeb E et al. Intraocular tolerance of Perfluorooctylbromide. (Perflubron) Retina. 15: 3, 1995.
21. Chang S, Sparrow JR, Iwamoto T, et al. Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina. 11: 367, 1991.
22. Falco L, Utari S, Esente S. Comparison of different perfluorocarbon liquids. J Vitreo Retina. 1: 17, 1992.
23. Grafstein D. Detectection, estimation and removal of impurities in fluorocarbon liquids. Anal Chem. 26: 523, 1954.
24. Sparrow JR, Ortiz R, MacLeish PR, et al. Fibroblast behavior at aqueous interfaces with perfluorocarbon, silicone oil and fluorosilicone liquids. Invest Ophthalmol Vis Sci. 31: 638, 1990.
25. Sargent JW, Seffl RJ. Properties of perfluorinated liquids. Fed Proc. 29: 1699, 1970.
26. Clark LJ. Whole animal perfusion with fluorocarbon dispersions. Fed Proc. 29: 1695, 1970.
27. Clark LJ, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science. 152: 1755, 1966.
28. Geyer R. "Bloodless" rats through the use of artificial blood substitutes. Fed Proc. 34: 1499, 1975.
29. Geyer R. Flouorocarbon-polyol artificial blood substitutes. N Eng J Med. 289: 1077, 1973.
30. DeMarchis J, Chang S, Ortiz R, et al. Electrophysiologic evaluation of short-term vitreous replacement by perfluorocarbon liquids. Invest Ophthalmol Vis Sci. 30 (suppl) 102, 1989.
31. Peyman GA, Conway MD, Soike KF, et al. Long-term vitreous replacement in primates with intravitreal Vitreon or Vitreon plus silicone. Ophthalmic Surg. 22: 657, 1991.
32. Gonvers M, Horning J-P, deCourten C. The effect of liquid silicone on the rabbit retina. Histologic and ultrastructural study. Arch Ophthalmol. 104: 1057, 1986.
33. Eckardt C. Treatment of complicated retinal detachment. Intraoperative use of perfluorodecalin. Ophthalmologie. 89: 22, 1992.
34. Berrocal MH, Chang S. Perfluorocarbon liquids in vitreous surgery. Ophthalmol Clin North America. 7: 67, 1994.
35. Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 90: 121, 1983.
36. Chang S, Wieland M, Zimmerman NJ. Results and complications of perfluorocarbon liquids in proliferative vitreoretinopathy. Presented at the 17th meeting of Club Jules Gonin, Lausanne, September 2-6, 1990.
37. Forlini C. Centrifugal surgical strategy with early introduction of PFCL in the managenment of retinal traction detachment: Effect on reproliferation. J Vitreo Retina. 1: 44, 1992.
38. Schulman JA, Peyman GA, Blinder KJ, et al. Management of giant retinal tears with perfluoroperhydrophenanthrene (Vitreon). Jpn J Ophthalmol. 37: 70, 1993.
39. McDonald HR, Lewis H, Aaberg T, et al. Complications of endodrainage retinotomies created during vitreous surgery for complicated retinal detachment. Ophthalmology. 96: 358, 1989.
40. Forlini C. Evaluation of use of heavy liquids in vitreoretinal surgery: Personal experiences. Vitreretinal Surg Technol. 5: 6, 1993.
41. Abrams GW, Williams GA, Neuwirth J, et al. Clinical results of titanium retinal tacks with pneumatic insertion. Am J Ophthalmol. 102: 13, 1986.
42. Ando, Kondo J. A plastic tack for the treatment of retinal detachment with giant tear (Letter). Am J Ophthalmol. 95: 260, 1983.
43. De Juan E Jr, McCuen BW II, Machemer R. The use of retinal tacks in the repair of complicated retinal detachments. Am J Ophthalmol. 102: 20, 1986.
44. O'Grady GE, Parel JM, Lee W, et al. Hypodermic stainless steel tacks and companion insertor designed for peripheral fixation of retina. Arch Ophthalmol. 106: 271, 1988.
45. Mathis A, Pagot V, David J. The use of perfluorodecalin in diabetic vitrectomy. For Der Ophthalmol. 88: 148, 1991.
46. Corcostegui B. Use of perfluorocarbon liquid in vitrectomy for diabetic rhegmatogenous retinal detachment. J Vitreo Retina 1: 30, 1992.
47. Mathis A. The use of perfluorodecalin in diabetic vitrectomy. J. Vitreo Retina. 1: 28, 1992.
48. Mester U, Rothe R, Zubcov A. Experimental studies with a high-density silicone oil for giant retinal tear. Ophthalmic Res 18: 81, 1986.
49. Hoffman M, Sorr E. Management of giant retinal tears without scleral buckling. Retina. 6: 197, 1986.
50. Kreissig I, Lincoff H, Stanowsky A. The treatment of giant tear detachments using retrohyaloidal perfluorocarbon gases without drainage or vitrectomy. Graefe's Arch Clin Exp Ophthalmol. 225: 94, 1987.
51. Kreiger A, Lewis H. Management of giant retinal tears without scleral buckling. Use of radical dissection of the vitreouys base and perfluoro-octane and intraocular tamponade. Ophthalmology. 99: 491, 1992.
52. LeMer Y, Kroll P. Liquid perfluorocarbon in treatment of giant tears. Klin Monatsbl Augenheilkd. 199: 256, 1991.
53. Glaser B, Carter J, Kuppermann B, et al. Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy. Ophthalmology. 98: 1613, 1991.
54. Desai UR, Peyman GA, Harper CA III, et al. The use of vitreon in the removal of massive vitreous hemorrhage caused by perforating ocular trauma. Invest Ophthalmol Vis Sci. 33 (suppl): 1314, 1992.
55. Desai UR, Peyman GA, Harper III. Perfluorocarbon liquids in traumatic vitreous hemorrhage and retinal detachment. Ophthalmic Surg. 24: 537, 1993.
56. Alfaro DV, Liggett PF. Perfluorocarbon liquids in the management of tarumatic retinal detachment. Vitreoretinal Surg Technol. 15: 1, 1993.
57. Resnick KI, Shapiro MJ, Kim S. Perfluorooctane as an instrument to manipulate intraocular foreign bodies. Invest Ophthalmol Vis Sci. 32 (suppl): 881, 1991.
58. Regillo CD, Vander JF, Duker JS, et al. Repair of retinitis related retinal retinal detachments with silicone oil in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 113: 21, 1992.
59. Jabs DA, Enger C, Haller J, et al. Retinal detachments in patients with cytomegaloretinitis. Arch Ophthalmol. 109: 794, 1991.
60. Sidikaro Y, Silver L, Holland GN, et al. Rhegmatogenous retinal detachments in patients with AIDS and necrotizing retinal infections. Ophthalmologhy. 98: 129, 1991.
61. Liu KR, Peyman GA, Chen M, et ai. Use of high density vitreous subsitutes in the removal of posteriorly dislocated lenses or intraocular lenses. Ophthalmology. 22: 503, 1991.
62. Peyman GA, Shulman JA. Intravitreal surgery: Principles and practice. Norwalk, Appleton- Century-Crofts. 1986. p 384.
63. Verma LK, Peyman GA, Wafapoor H, et al. An analysis of posterior segment complications after vitrectomy using the perfluorocarbon perfluoroperhydrophenanthrene (Vitreon). Ophthalmic Surg. 26: 29, 1995
64. Peyman GA, Schulman JA, Sullivan B. Perfluorocarbon liquids in Ophthalmology. Survey Ophthalmol. 39: 375, 1995.
65. Wallace RT, McNamara JA, Brown G. The use of perfluorophenanthrene in the removal of intravitreal lens fragments. Am J Ophthalmol. 116: 196, 1993.
66. Le Mer Y, Haut J, Van Effenterre G, et al. Use of perfluorocarbon liquid in the management of posterior dislocation of lens. J Vitreo Retina. 1: 52, 1992.
67. Greve MDJ, Peyman GA, Mehta NJ, et al. Use of perfluoroperhydrophenanthrene in the management of posteriorly dislocated crystalline and intraocular lenses. Ophth Surg. 24: 593, 1993.
68. Van Effenterre G, Le Mer Y, Lacotte JL, et al. Luxation posterieure du cristallin ou d'un implant: Traitement chirurgical utilisant un perfluorocarbone liquide. J Fr Ophthalmol. 15: 337, 1992.
69. Brod RD, Flynn HW Jr, Clarkson JG, et al. Management options for retinal detachment in the peresence of a posteriorly dislocated intraocular lens. Retina. 10: 50, 1990.
70. Lewis H, Blumenkranz MS, Chang S. Treatment of crystalline lens and retinal detachment with perfluorocarbon liquids. Retina. 12: 299, 1992.
71. Lambert HM, Capone A Jr, Aaberg TM, et al. Surgical excision of subfoveal neovascular membranes in age-related macular degenaration. Am J Ophthalmol. 113: 257, 1992.
72. Forlini C, Del Fiume E, Cicognani A, et al. Use of PFCLs in the surgical management of endophthalmitis: New indicators. J Vitreo Retina. 1: 55, 1992.
73. Claes C, Zivojnovic R. The use of perfluorocarbon liquids in vitreous surgery. Bulletin De La Societe Belge D Ophthalmologie. 238: 145, 1990.
74. Millsap CM, Peyman GA, Ma PE, et al. The surgical mangement of retinopathy of prematurity using a perfluorocarbon liquid Int Ophthalmol. 18: 97, 1994.
75. Lee K, Peyman GA, Paris C, et al. Management of retinal detachment associated with choroidal coloboma using perfluoroperhydrophenanthrene (Vitreon). Ophthalmic Surg. 23: 553, 1992.
76. Desai UR, Peyman GA, Chen CJ et al. Use of Perfluoro perhydro phenanthrene in the management of suprachoroidal haemorrhage. Ophthalmol. 99: 1992, 1542-7.
77. Cibis PA, Becker B, Okun E, et al. The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol. 68: 590, 1962.
78. Scott JD. Silicone oil as an instrument. In: Ryan SJ, ed. Retina, Vol. III. St Louis, CV Mosby. 1994, p 2181.
79. Haut J, Ulleren M, Boulard ML, et al. Utilisation du silicone intra-oculaire apres vitrectomie comme troitement des restrictions massive in vitre (note preliminaire). Bull Soc Ophthalmol Fr. 78: 361, 1978.
80. Zivojnovic R. Silicone oil in vitreo retinal surgery. Dordrecht, The Netherlands, Martinus Nijhoff/Dr W Junk, 1987.
81. Reidel KG, Gabel VP, Neubaur L, et al. Intravitreal silicone oil injection. Complications and treatment of 415 consecutive patients. Graefe's Arch Clin Exp Ophthalmol. 228: 19, 1990.
82. Lucke K, Laqua H. Silicone oil in the treatment of complicated retinal detachments. Berlin, Springer- Verlag. 1990.
83. Lean JS. Use of silicone oil as an additional technique in vitreoretinal surgery. In: Ryan SJ, ed. Retina. St. Louis, CV Mosby. 1989, p 279.
84. Crisp A, dejuan E Jr, Tiedeman J. Effect of silicone oil viscocity on emulsification. Arch Ophthalmol. 105: 546, 1987.
85. Gabel VP, Kampik A, Burkhardt J. Analysis of intraocular applied silicone oils of various origins. Graefe's Arch Clin Exp Ophthalmol. 225: 100, 1987.
86. Trask DK, Richard-James Inc. Product information Silikon 1000 and silikon 5000 (technical manual) 1991, pp 1-8.
87. Petersen J. The physical and surgical aspects of silicone oil in the vitreous cavity. Graefe's Arch Clin Exp Ophthalmol. 225: 454, 1987.
88. Parel JM. Silicone oils. Physicochemical properties. In: Ryan SJ, ed. Retina. St. Louis, CV Mosby. 1989, p 261.
89. Glaser BM, de Bustros S, Michels RG. Postoperative retinal breaksoccurring after intravitreal silicone oil injection. Retina. 4: 246, 1984.
90. Lewis H, Burke JM, Abrams GW. Perisilicone proliferation after vitrectomy for proliferative vitreoretinopathy. Ophthalmology. 95: 583, 1988.
91. Machemer R. The importance of fluid absorption, traction, intraocular currents and chorioretinal scars in the therapy of rhegmatogenous retinal detachments. Am J Ophthalmol. 98: 681, 1984.
92. Hutton WL, Fuller DG. Silicone oil in treatment of retinal disease. Ophthalmol Clin North America. 7: 89, 1994.
93. McCuen BW II, de Juan E Jr, Machemer R. Silicone oil in vitreoretinal surgery. Part I. Surgical techniques. Retina. 5: 189, 1985.
94. McCuen BW II, Landers MB, Machemer R. The use of silicone oil following failed vitrectomy for retinal detachment and advanced proliferative vitreoretinopathy. Ophthalmology. 92: 1029, 1985.
95. Hutton WL, Fuller DL, Synder WB. Silicone oil for management of PVR: Comparison of six-month and two-year results. In: Freeman HM, Tolentino FI, eds. Proliferative vitreoretinopathy. New York, Spriger-Verlag. 1988, p 166.
96. Leaver PK, Lean JS. Management of giant retinal tears using vitrectomy and silicone oil/fluid exchange. Trans Ophthalmol Soc U.K. 101: 189, 1981.
97. Ando F, Miyake Y, Oshima K, et al. Temporary use of intraocular silicone in the treatment of complicated retinal detachment Graefe's Arch Clin Exp Ophthalmol. 224: 32: 1984.
98. Gonvers M. Temporary silicone oil tamponade in the management of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 100: 239, 1985.
99. de Bustros S, Michels RG. Surgical treatment of retinal detachment complicated by proliferative vitreoretinopathy. Am J Ophthalmol. 98. 694, 1984.
100. Jalkh AE, Avila MP, Schepens CL, et al. Surgical treatment of proliferative vitreoretinopathy. Arch Ophthalmol. 102: 1135, 1984.
101. Sternberg P, Machemer R. Results of conventional vitreous surgery for proliferative vitreoretinopathy. Am J Ophthalmol. 100: 141, 1985.
102. DeCorral LR, Peyman GA. Pars plana vitrectomy and intravitreal silicone oil injection in eyes with rubeosis irides Can J Ophthalmol. 21: 10, 1986.
103. Machemer R. Massive periretinal proliferation : A logical approach to therapy. Trans Am Ophthalmol Soc. 75: 556, 1977.
104. Cox MS, Trese MT, Murphy PL. Silicone oil after advanced proliferative vitreoretinopathy. Ophthalmology. 93: 636, 1986.
105. Lean JS, Leaver PK, Cooling RJ. Management of complex retinal detachments by vitrectomy and fluid silicone oil exchange. Trans Ophthalmol Soc U.K. 102: 203, 1982.
106. Haut J, Larricart JP, Van Effenterre G, et al. Some of the most important properties of silicone oil to explain its action. Ophthalmologica. 191: 150, 1985.
107. Watzke RC. Silicone retinopoiesis for retinal detachment surgery. Arch Ophthalmol. 77: 185, 1967.
108. Chan C, Okun E. The question of ocular tolerance to intravitreal liquid silicone oil. Ophthalmology. 93: 651, 1986.
109. McCuen BW II, de Juan E, Landers MB, et al. Silicone oil in vitreo retinal surgery. Part 2. Results and complications. 5: 198, 1985.
110. The Silicone Study Group : Vitrectomy with silicone oil or sulphur hexafluoride gas in eyes with severe proliferative vitreoretinopathy : Results of a randomized clinical trial. Silicone study report 1. Arch Ophthalmol. 110:770, 1992.
111. The Silicone Study Group : Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy : results of a randomized clinical trial. Silicone study report 2. Arch Ophthalmol. 110:781, 1992.
112. The Silicone Study Group : Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone study report 3 Retina. 13: 279, 1993.
113. The Silicone Study Group : Postoperative intraocular pressure abnormalities in the silicone study. Silicone study report 4. Ophthalmology. 100:1629, 1993.
114. The Silicone Study Group : Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone oil report 5 Am J Ophthalmol. 116:557, 1993
115. The Silicone Study Group : The effect of silicone oil removal. Silicone study report 6. Arch Ophthalmol. 112:778, 1994.
116. The Silicone Study Group : The incidence of cornealabnormalities in the silicone study. Arch. Ophthalmol. 113:764, 1995.
117. Benson WE, Brown GC, Tasman W, et al. Complications of vitrectomy for non-clearing vitreous hemorrhage in diabetic patients. Ophth Surg. 19: 862, 1988.
118. Flynn HW Jr, Chew EY, et al. Pars plana vitrectomy in the early treatment of diabetic retinopathy study. ETDRS report No. 17. Ophthalmology. 99: 1351, 1992.
119. Gabel VP, Beck P. Does silicons oil improve the prognosis of severe proliferative diabetic retinopathy? Klin Monatsbl Augenheilkd. 197: 112: 1990.
120. Thompson JT, deBustros S, Michels RG, et al. Results of vitrectomy for proliferative diabetic retinopathy. Ophthalmol. 93: 1571, 1986.
121. Brourman ND, Blumenkranz MS, Cox MS, et al. Silicone oil for treatment of severe proliferative diabetic retinopathy. Ophthalmology. 96: 759, 1989.
122. McCuen BW II, Rincoff JS. Silicone oil for progressive anterior ocular neovascularization after failed diabetic vitrectomy. Arch Ophthalmol. 107: 677, 1989.
123. De Juan E, Hardy M, Hatchell DL, et al. The effect of intraocular silicone oil on anterior chamber oxygen pressure in cats. Arch Ophthalmol. 104: 1063, 1986.
124. Rinkoff JS, de Juan E, McCuen BW II. Silicone oil for retinal detachment with advanced proliferative vitreoretinopathy following failed vitrectomy for proliferative diabetic retinopathy. Am J Ophthalmol. 101: 181, 1986.
125. Heimann K, Dahl B, Dimopoulos S, et al. Pars plana vitrectomy and silicone oil injection in proliferative diabetic retinopathy. Graefe's Arch Clin Exp Ophthalmol. 227: 152, 1989.
126. E, Bornfeld N, Oehlschager V, et al. Epiretinal membrane formation after pars plana vitrectomy in proliferative diabetic retinopathy. Klin Monatsbl Augenheilkd. 200: 267, 1992.
127. Scott JD. Treatment of massive vitreous retraction by the separation of the preretinal membrane using liquid silicone. Mod Probl Ophthalmol. 15: 285, 1975.
128. Alexandribes E. Silicone oil tamponade in management of severe hemorrhagic detachment of the choroid and ciliary body after surgical trauma. Ophthalmology. 200: 189, 1990.
129. Freeman WR, Quinceno JI, Crapotta JA, et al. Surgical repair of rhegmatogenous retinal detachment in immunosuppressed patients with cytomegaloretinitis. Ophthalmology. 99; 466, 1992.
130. Dugel PU, Ligett PE, Ziogas A, et al. Repair of retinal detachments caused by cytomegalovirus retinitis in aptients with acquired immunodeficiency syndrome. Am J Ophthalmol. 112: 235, 1991.
131. Gopal L, Badrinath SS, Sharma T, Parikh SN, Biswas J. Pattern of retinal breaks and retinal detachment in eyes with choroidal coloboma. Ophthalmology. 102: 1212-1217, 1995.
132. Gopal L, Kini MM, Badrinath SS, Sharma T. Management of retinal detachment with choroidal coloboma. Ophthalmology. 98: 1622-27, 1991.
133. Chung H, Acosta J, Refojo MJ, et al. Use of high- density fluorosilicone oil in open sky vitrectomy. Retina. 7: 180, 1987.
134. Peyman GA, Smith TA. Ues of fluorosilicone oil to unfold a giant retinal tear. Int Ophthalmol. 10: 149, 1987.
135. Sparrow JR, Mathews GP, Iwamoto T, et al. Retinal tolerance to intravitreal perfluoroethyl- cyclohexane liquid in the rabbit. Retina. 13: 56, 1993.
136. Blinder KJ, Peyman GA, Desai UR, et al. Vitreon, a short-term vitreoretinal tamponade. Br J Ophthalmol. 76: 240, 1992.
137. Peyman GA, Blinder KJ, Paris C, et al. Vitreon: A new perfluorocarbon vitreous substitute. Afro- Asian J Ophthalmol. 10: 48, 1991.
138. Scott JD. Use of liquid silicone in vitrectomized eyes. Dev Ophthalmol. 2: 185, 1981.
139. Leaver PK. Complications of intraocular silicone oil. In: Ryan SJ, ed. Retina. St. Louis, CV Mosby. 1989, p 293.
140. Gonver M. Temporary silicone oil tamponade in the treatment of complicated retinal detachments. Graefe's Arch Clin Exp Ophthalmol. 228: 415, 1990.
141. Ando F. Intraocular hypertension resulting from pupillary block by silicone oil. Am J Ophthalmol. 99: 87, 1985.
142. Madreperala SA, McCuen BW II. Inferior peripheral iridectomy in patients receiving silicone oil. Retina. 15: 87, 1995.